Drug Liposome Partitioning as a Tool for the Prediction of Human Passive Intestinal Absorption
暂无分享,去创建一个
[1] Shiyin Yee,et al. In Vitro Permeability Across Caco-2 Cells (Colonic) Can Predict In Vivo (Small Intestinal) Absorption in Man—Fact or Myth , 1997, Pharmaceutical Research.
[2] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .
[3] K. Lauritsen,et al. Clinical pharmacolinetics of drugs used in the treatment of gastrointestinal diseases. I , 1990 .
[4] B. Brodie,et al. The gastric secretion of drugs: a pH partition hypothesis. , 1957, The Journal of pharmacology and experimental therapeutics.
[5] J. Jensen,et al. Clinical pharmacokinetics of terbinafine (Lamisil) , 1989, Clinical and experimental dermatology.
[6] P. Routledge,et al. Clinical Pharmacokinetics of Propranolol , 1979, Clinical pharmacokinetics.
[7] L. S. Wan,et al. CMC of polysorbates. , 1974, Journal of pharmaceutical sciences.
[8] J. Rask-Madsen,et al. Clinical Pharmacokinetics of Drugs Used in the Treatment of Gastrointestinal Diseases (Part I) , 1990, Clinical pharmacokinetics.
[9] P. de Miranda,et al. Pharmacokinetics of acyclovir after intravenous and oral administration. , 1983, The Journal of antimicrobial chemotherapy.
[10] P. Finholt,et al. Dissolution kinetics of drugs in human gastric juice--the role of surface tension. , 1968, Journal of pharmaceutical sciences.
[11] M. L. La Rotonda,et al. Interactions of nonsteroidal antiinflammatory drugs with phospholipids: comparison between octanol/buffer partition coefficients and chromatographic indexes on immobilized artificial membranes. , 1997, Journal of pharmaceutical sciences.
[12] W. Frishman. Atenolol and Timolol, Two New Systemic β-Adrenoceptor Antagonists , 1982 .
[13] S. Adams,et al. The metabolism of ibuprofen. , 1973, Xenobiotica; the fate of foreign compounds in biological systems.
[14] G Folkers,et al. Review of theoretical passive drug absorption models: historical background, recent developments and limitations. , 1996, Pharmaceutica acta Helvetiae.
[15] L Lemberger,et al. Fluoxetine: clinical pharmacology and physiologic disposition. , 1985, The Journal of clinical psychiatry.
[16] H. Breithaupt,et al. Kinetics of allopurinol after single intravenous and oral doses , 2004, European Journal of Clinical Pharmacology.
[17] Klaus-Jürgen Schaper. Absorption of Ionizable Drugs: Nonlinear Dependence on log P, pKa and pH ‐ Quantitative Relationships , 1982 .
[18] D. Leahy,et al. Partition and distribution coefficients of solutes and drugs in brush border membrane vesicles. , 1993, Biochemical pharmacology.
[19] T. Blaschke,et al. Clinical Pharmacokinetics of Rifabutin , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] A. Avdeef,et al. pH-metric log P. II: Refinement of partition coefficients and ionization constants of multiprotic substances. , 1993, Journal of pharmaceutical sciences.
[21] T. Yue,et al. Carvedilol-liposome interaction: evidence for strong association with the hydrophobic region of the lipid bilayers. , 1996, Biochimica et biophysica acta.
[22] G. Amidon,et al. Absorption potential: estimating the fraction absorbed for orally administered compounds. , 1985, Journal of pharmaceutical sciences.
[23] Alex Avdeef,et al. pH‐Metric log P. Part 1. Difference Plots for Determining Ion‐Pair Octanol‐Water Partition Coefficients of Multiprotic Substances , 1992 .
[24] A. Avdeef,et al. pH-Metric logP 10. Determination of Liposomal Membrane-Water Partition Coefficients of lonizable Drugs , 1998, Pharmaceutical Research.
[25] D Mackay,et al. A novel method for measuring membrane-water partition coefficients of hydrophobic organic chemicals: comparison with 1-octanol-water partitioning. , 1988, Journal of Pharmacy and Science.
[26] Hans Lennernäs,et al. Does Fluid Flow Across the Intestinal Mucosa Affect Quantitative Oral Drug Absorption? Is It Time for a Reevaluation? , 1995, Pharmaceutical Research.
[27] Y. Thériault,et al. NMR study of the interaction of beta-blockers with sonicated dimyristoylphosphatidylcholine liposomes in the presence of praseodymium cation. , 1989, Membrane biochemistry.
[28] K. Goa,et al. Olanzapine. A review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses. , 1997, Drugs.